BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28
• 31

• Drug Development

  BioSante Pharmaceuticals, Inc. Initiates Third LibiGel(R) Phase III Trial in the Treatment of Female Sexual Dysfunction under an SPA

  March 19, 2008

   · 

  1 min read
• Drug Development

  Sirtris Pharmaceuticals Announces First U.S. Patent Issued On Class of SIRT1 Activators; Patent Covers First NCE to Enter Human Clinical Trials

  March 19, 2008

   · 

  1 min read
• Business

  Optimer Pharmaceuticals, Inc. to Host Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2007 Financial Results

  March 19, 2008

   · 

  1 min read
• Pharm Country

  Wall Street Media Presents a Video of Dr. Gordon Brandt, President of Nastech Pharmaceutical Company Inc.

  March 19, 2008

   · 

  1 min read
• Drug Development

  Medivir AB: Lipsovir(R) Prevents Cold Sores - Phase III Clinical Trial Results First to Show Prevention by Early Treatment

  March 19, 2008

   · 

  1 min read
• Pharm Country

  Burnham Institute for Medical Research to Ring NASDAQ Opening Bell

  March 19, 2008

   · 

  1 min read
• 2008 Frost & Sullivan European Advanced Imaging Informatics Product Innovation Award Conferred on Visage Imaging

  March 19, 2008

   · 

  1 min read
• BioForest

  FEI Company Receives Award for Titan S/TEM at Nano Tech 2008 in Japan

  March 19, 2008

   · 

  1 min read
• Deals

  Samaritan Pharmaceuticals, Inc. Acquires Commercialization Rights to Market and Distribute Abiogen Pharma’s Cancer Drug Abioklad in Greece, Cyprus and Turkey

  March 19, 2008

   · 

  1 min read
• Policy

  Supplemental Application for GARDASIL(R), Merck & Co., Inc.'s Cervical Cancer Vaccine, Designated Priority Review by the U.S. FDA for Use in Women 27 through 45

  March 19, 2008

   · 

  6 min read